| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of General Virology, Vol 78, 2497-2501, Copyright © 1997 by Society for General Microbiology
ARTICLES |
YL Chen, PW Ts'ai, CC Yang and CT Wang
Institute of Clinical Medicine, National Yang-Ming University, and Department of Medical Research and Education, Veterans General Hospital- Taipei, Taiwan, Republic of China.
We have demonstrated that COS7 cells transiently co-expressing myristylation-defective (Myr-) and protease-defective (PR-) human immunodeficiency virus (HIV) mutants can release infectious virions when co-transfected with an amphotropic murine leukaemia virus envelope protein expression plasmid (SV-A-MLV-env). In contrast, no infectious virions were detected when a PR-, noninfectious HIV gag mutant was co- expressed with the Myr- mutant, although the Myr- mutant could still process the immature core particles in trans. This result indicates that generation of functionally normal Gag proteins is required for virus infectivity in our complementation system. A mutant with a 56- amino-acid deletion in the N-terminal region of the capsid (CA) domain could still complement the PR- mutant to generate infectious virions, suggesting that the deletion mutant could provide a functional protease for processing in the PR- mutant. This result is consistent with the concept that mutations within the N-terminal region of the CA domain have no major effects on Gag-Pol incorporation into particles.
This article has been cited by other articles:
|
|
 |
|
  H.-C. Chiu, F.-D. Wang, Y.-M. A. Chen, and C.-T. Wang Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing J. Gen. Virol., July 1, 2006; 87(7): 2041 - 2046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Abdurahman, S. Hoglund, L. Goobar-Larsson, and A. Vahlne Selected amino acid substitutions in the C-terminal region of human immunodeficiency virus type 1 capsid protein affect virus assembly and release J. Gen. Virol., October 1, 2004; 85(10): 2903 - 2913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Hill, C. W. Hooker, D. Harrich, S. M. Crowe, and J. Mak Gag-Pol Supplied in trans Is Efficiently Packaged and Supports Viral Function in Human Immunodeficiency Virus Type 1 J. Virol., August 1, 2001; 75(15): 6835 - 6840. [Abstract] [Full Text]
|
|
|
|
|
|
C.-T. Wang, Y.-C. Chou, and C.-C. Chiang Assembly and Processing of Human Immunodeficiency Virus Gag Mutants Containing a Partial Replacement of the Matrix Domain by the Viral Protease Domain J. Virol., April 1, 2000; 74(7): 3418 - 3422. [Abstract] [Full Text]
|
|
|
|
|
|
C.-T. Wang, H.-Y. Lai, and J.-J. Li Analysis of Minimal Human Immunodeficiency Virus Type 1 gag Coding Sequences Capable of Virus-Like Particle Assembly and Release J. Virol., October 1, 1998; 72(10): 7950 - 7959. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
